22157.jpg
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Epidemiology Report 2022-2032: Focus on United States, Germany, Spain, Italy, France, United Kingdom, and Japan
09 mars 2022 06h18 HE | Research and Markets
Dublin, March 09, 2022 (GLOBE NEWSWIRE) -- The "Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Epidemiology Forecast to 2032" report has been added to ResearchAndMarkets.com's...
Global Idiopathic Pulmonary Fibrosis Market
Global Idiopathic Pulmonary Fibrosis (IPF) Industry Forecast, 2030 - Competitive Landscape Assessment, Product Development & Innovation, Case Reports, Marketed Products & Emerging Therapies
28 févr. 2022 06h23 HE | Research and Markets
Dublin, Feb. 28, 2022 (GLOBE NEWSWIRE) -- The "Global Idiopathic Pulmonary Fibrosis Market, By Therapy, Estimation & Forecast, 2017-2030" report has been added to ResearchAndMarkets.com's...
Global Pulmonary Drugs Market
The Worldwide Pulmonary Drugs Industry is Expected to Reach $69+ Billion by 2027
02 févr. 2022 05h18 HE | Research and Markets
Dublin, Feb. 02, 2022 (GLOBE NEWSWIRE) -- The "Global Pulmonary Drugs Market (2021-2027) by Drug Class, Indication, Distribution Channel, and Geography, IGR Competitive Analysis, Impact of Covid-19,...
22157.jpg
Global Idiopathic Pulmonary Fibrosis (IPF) Market Report 2021: Market was Valued at $3271.3 Million in 2020 - Forecast to 2026
20 janv. 2022 04h43 HE | Research and Markets
Dublin, Jan. 20, 2022 (GLOBE NEWSWIRE) -- The "Global Idiopathic Pulmonary Fibrosis (IPF) Market - Analysis By Drug Type, End User, By Region, By Country (2021 Edition): Market Insights, Pipeline...
22157.jpg
Global Nasal Polyps Treatment Market Report 2021: A $4,243.9 Million Market by 2030
10 déc. 2021 04h48 HE | Research and Markets
Dublin, Dec. 10, 2021 (GLOBE NEWSWIRE) -- The "Global Nasal Polyps Treatment Market Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering....
22157.jpg
Global Anti-Asthmatics and COPD Drugs Markets Report 2021: Top 10 in Sales are Ellipta, Symbicort, Spiriva, Advair, Nucala, Xolair, Ventolin, Pulmicort, Fasenra, Flovent
09 déc. 2021 03h33 HE | Research and Markets
Dublin, Dec. 09, 2021 (GLOBE NEWSWIRE) -- The "Anti-Asthmatics and COPD Drugs Global Market Opportunities and Strategies to 2030: COVID-19 Implications and Growth" report has been added to...
22157.jpg
Global Trikafta Market Research Report 2021: Patents, Dosage & Prices, Sales, Clinical Trials, Chemistry & Pharmacokinetic Properties, Reimbursement Scenario - Outlook to 2028
08 déc. 2021 07h28 HE | Research and Markets
Dublin, Dec. 08, 2021 (GLOBE NEWSWIRE) -- The "Trikafta Patent, Sales & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. Global Trikafta market is...
22157.jpg
COPD Epidemiology Analysis 2018-2020 and Forecasts 2021-2030 for the US, Germany, France, Italy, Spain, UK and Japan
02 déc. 2021 05h03 HE | Research and Markets
Dublin, Dec. 02, 2021 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease (COPD) - Epidemiology Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. This report...
22157.jpg
The Worldwide Lung Injury Industry is Expected to Reach $2+ Billion by 2030
05 nov. 2021 08h23 HE | Research and Markets
Dublin, Nov. 05, 2021 (GLOBE NEWSWIRE) -- The "Lung injury Market by Therapy, Injury Type, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to...
22157.jpg
Global Pneumonia Therapeutics Market (2021 to 2030) - by Therapeutics, Distribution Channel, Age Group and Region
05 nov. 2021 08h08 HE | Research and Markets
Dublin, Nov. 05, 2021 (GLOBE NEWSWIRE) -- The "Pneumonia Therapeutics Market by Therapeutics, Distribution Channel, and Age Group: Global Opportunity Analysis and Industry Forecast, 2021-2030"...